4//SEC Filing
Flagship Ventures Fund IV General Partner LLC 4
Accession 0000899243-20-032200
CIK 0001609809other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 6:00 PM ET
Size
34.3 KB
Accession
0000899243-20-032200
Insider Transaction Report
Form 4
Transactions
- Other
Common Stock
2020-11-23−642,180→ 1,283,282 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−3,587,820→ 4,434,600 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−966,234→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,481,481→ 2,962,963 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,186,310→ 3,258,134 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−43,154→ 0 total(indirect: See Footnote)
Holdings
- 376,018(indirect: See Footnote)
Common Stock
- 2,734,994(indirect: See Footnote)
Common Stock
Flagship Ventures Fund IV-Rx, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-11-23−3,587,820→ 4,434,600 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−966,234→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,481,481→ 2,962,963 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−43,154→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,186,310→ 3,258,134 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−642,180→ 1,283,282 total(indirect: See Footnote)
Holdings
- 2,734,994(indirect: See Footnote)
Common Stock
- 376,018(indirect: See Footnote)
Common Stock
Flagship Pioneering, LLC
10% Owner
Transactions
- Other
Common Stock
2020-11-23−43,154→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,481,481→ 2,962,963 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−966,234→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−642,180→ 1,283,282 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−3,587,820→ 4,434,600 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,186,310→ 3,258,134 total(indirect: See Footnote)
Holdings
- 376,018(indirect: See Footnote)
Common Stock
- 2,734,994(indirect: See Footnote)
Common Stock
AFEYAN NOUBAR
Director10% Owner
Transactions
- Other
Common Stock
2020-11-23−3,587,820→ 4,434,600 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,186,310→ 3,258,134 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−43,154→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,481,481→ 2,962,963 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−642,180→ 1,283,282 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−966,234→ 0 total(indirect: See Footnote)
Holdings
- 2,734,994(indirect: See Footnote)
Common Stock
- 376,018(indirect: See Footnote)
Common Stock
Transactions
- Other
Common Stock
2020-11-23−642,180→ 1,283,282 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,481,481→ 2,962,963 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−966,234→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,186,310→ 3,258,134 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−3,587,820→ 4,434,600 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−43,154→ 0 total(indirect: See Footnote)
Holdings
- 2,734,994(indirect: See Footnote)
Common Stock
- 376,018(indirect: See Footnote)
Common Stock
Transactions
- Other
Common Stock
2020-11-23−966,234→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−3,587,820→ 4,434,600 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,186,310→ 3,258,134 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−642,180→ 1,283,282 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,481,481→ 2,962,963 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−43,154→ 0 total(indirect: See Footnote)
Holdings
- 376,018(indirect: See Footnote)
Common Stock
- 2,734,994(indirect: See Footnote)
Common Stock
Flagship Ventures Fund IV, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-11-23−642,180→ 1,283,282 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−3,587,820→ 4,434,600 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,186,310→ 3,258,134 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−43,154→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−966,234→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,481,481→ 2,962,963 total(indirect: See Footnote)
Holdings
- 376,018(indirect: See Footnote)
Common Stock
- 2,734,994(indirect: See Footnote)
Common Stock
Nutritional Health LTP Fund, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-11-23−642,180→ 1,283,282 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−966,234→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,481,481→ 2,962,963 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−43,154→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−3,587,820→ 4,434,600 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,186,310→ 3,258,134 total(indirect: See Footnote)
Holdings
- 2,734,994(indirect: See Footnote)
Common Stock
- 376,018(indirect: See Footnote)
Common Stock
Flagship Pioneering Fund VI, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-11-23−642,180→ 1,283,282 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−966,234→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−43,154→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,186,310→ 3,258,134 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−1,481,481→ 2,962,963 total(indirect: See Footnote) - Other
Common Stock
2020-11-23−3,587,820→ 4,434,600 total(indirect: See Footnote)
Holdings
- 376,018(indirect: See Footnote)
Common Stock
- 2,734,994(indirect: See Footnote)
Common Stock
Footnotes (11)
- [F1]On November 23, 2020, Flagship Ventures Fund IV, L.P. ("Flagship Fund IV") and Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx") distributed to its limited partners and sole general partner, Flagship Ventures Fund IV General Partner, LLC ("Flagship Fund IV GP"), pro rata and without consideration, 3,587,820 shares and 642,180 shares, respectively, of the Issuer's common stock. Flagship Fund IV GP, in turn, distributed to its members, pro rata and without consideration, the 837,782 shares and 128,452 shares it received from Flagship Fund IV and Flagship Fund IV-Rx, respectively. Noubar B. Afeyan, Ph.D. received 335,171 shares through Flagship Fund IV GP's distribution. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.
- [F10]Shares held by Flagship VentureLabs IV LLC ("VentureLabs IV"). Flagship Fund IV is a member of VentureLabs IV and also serves as its manager. Each of the reporting persons except VentureLabs IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F11]Shares held by Noubar B. Afeyan, Ph.D. Each of the reporting persons except for Noubar B. Afeyan, Ph.D. disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Includes 12,853 shares held through a trust for the benefit of Dr. Afeyan's children. Dr. Afeyan disclaims Section 16 beneficial ownership of these shares except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares for Section 16 or any other purpose.
- [F2]Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Edwin M. Kania, Jr. is retired both from Flagship Pioneering and as a manager of Flagship Fund IV GP.
- [F3]Shares held by Flagship Fund IV-Rx. Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F4]Shares held by Flagship Fund IV GP. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV GP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F5]On November 23, 2020, Nutritional Health LTP Fund, L.P. ("Nutritional LTP") distributed to its limited partners, pro rata and without consideration, 1,186,310 shares of the Issuer's common stock. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.
- [F6]Shares held by Nutritional LTP. Nutritional Health LTP Fund General Partner LLC ("Nutritional LTP GP") is the general partner of Nutritional LTP. Noubar B. Afeyan Ph.D. is the sole member and manager of Nutritional LTP GP. Each of the reporting persons except for Nutritional LTP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F7]On November 23, 2020, Flagship Pioneering Fund VI, L.P. ("Flagship Fund VI") distributed to its limited partners and sole general partner, Flagship Pioneering Fund VI General Partner LLC ("Flagship Fund VI GP"), pro rata and without consideration, 1,481,481 shares of the Issuer's common stock. Flagship Fund VI GP, in turn, distributed to its members, pro rata and without consideration, the 43,154 shares it received from Flagship Fund VI. Each of Noubar B. Afeyan, Ph.D. and a trust for the benefit of Dr. Afeyan's children received 12,853 shares through Flagship Fund VI GP's distribution. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.
- [F8]Shares held by Flagship Fund VI. Flagship Fund VI GP is the general partner of Flagship Fund VI. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Fund VI GP. Noubar B. Afeyan Ph.D. is the CEO, sole shareholder and director of Flagship Pioneering. Each of the reporting persons except Flagship Fund VI disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F9]Shares held by Flagship Fund VI GP. Flagship Pioneering is the manager of Flagship Fund VI GP. Noubar B. Afeyan Ph.D. is the CEO, sole shareholder and director of Flagship Pioneering. Each of the reporting persons except Flagship Fund VI GP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001508051
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 6:00 PM ET
- Size
- 34.3 KB